|
Aug 4
|
Swiss Stocks Tumble as Trump's 39% Tariff Spooks Investors
|
|
Aug 4
|
Swiss Stocks Decline on US Tariffs, Push for Lower Drug Prices
|
|
Aug 3
|
Swiss Gird for Stocks to Fall as Markets Reopen After Tariff Hit
|
|
Aug 2
|
Illumina: Will big Pharma come to its rescue? Its CEO thinks so.
|
|
Aug 1
|
Genentech’s Susvimo Maintains Vision Over Five Years With Two Refills Per Year in People With Wet Age-Related Macular Degeneration (AMD)
|
|
Aug 1
|
Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)
|
|
Aug 1
|
CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down
|
|
Aug 1
|
ALNY Q2 Earnings Top Estimates on Higher Amvuttra Revenues, Stock Up
|
|
Aug 1
|
Switzerland, the land of luxury brands, could see prices skyrocket from Trump's 39% tariffs
|
|
Aug 1
|
Regeneron Stock Rises on Q2 Earnings and Sales Beat, Eylea HD Sales Up
|
|
Aug 1
|
Global Pharma Stocks Fall After Trump Demands Cuts in Drug Prices
|
|
Aug 1
|
Trump Unleashes Massive Tariffs on Swiss Watches, Pharma Firms
|
|
Aug 1
|
Testicular Cancer Market Analysis and Forecast Report 2025-2035 | Emerging Trends Highlight Shift Towards Immunotherapy in Testicular Cancer
|
|
Jul 31
|
What Trump's Big Pharma CEO letters mean for drug pricing power
|
|
Jul 31
|
Biomarkers may address unmet needs of idiopathic pulmonary fibrosis treatment
|
|
Jul 31
|
AbbVie Beats on Q2 Earnings & Sales, Stock Up on Raised '25 EPS View
|
|
Jul 31
|
Biogen's Q2 Earnings & Sales Beat, 2025 Outlook Raised, Stock Up
|
|
Jul 31
|
Renal Failure Clinical Trials Market Landscape Report 2025 Featuring Bayer, AstraZeneca, Amgen, Sanofi, Novartis, AbbVie, Roche, Pfizer, Takeda, Astellas
|
|
Jul 31
|
Multiple Sclerosis Clinical Trials Market Landscape Report 2025 Featuring Biogen, Novartis, Sanofi, Merck, Teva, Bayer, Roche, Bristol-Myers Squibb, Laboratory Corp of America, IQVIA
|
|
Jul 30
|
Roche pushes ahead with late-comer strategy in obesity
|